About the ATC
The Advanced Technology Consortium (ATC) for Clinical Trials Quality Assurance
is supported by a National Cancer Institute U24 grant to Washington University.
It has grown out of the efforts of Washington University and the Radiation Therapy
Oncology Group, beginning in 1994, to create a robust
Quality Assurance process to collect and review
the image-based planning and verification data for patients enrolled on the
3D Oncology Group (3DOG) prostate dose-escalation protocol (RTOG 9406).
The ATC now functions as a "virtual entity" made up of the following clinical trials QA Centers:
The ATC capitalizes on the existing infrastructure and strengths of national QA programs. Its overall mission is to facilitate and support NCI sponsored advanced technology clinical trials, particularly those requiring digital data submission. This effort includes radiation therapy QA, image and radiation therapy digital data management, and clinical research and developmental efforts. Efforts are made to utilize each group's strengths and avoid duplication of existing programs. We strongly believe that advanced medical informatics can create an environment in which clinical investigators can receive, share, and analyze volumetric, multimodality treatment planning and verification digital data. Our ultimate goal is to improve the standards of care in the management of cancer by improving the quality of clinical trials medicine.